Sprinklr (CXM) Tops Q3 EPS by 2c, Beats on Revenue; Offers FY25 Guidance
Go back to Sprinklr (CXM) Tops Q3 EPS by 2c, Beats on Revenue; Offers FY25 Guidance| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 5.39 +0.06 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.33 | 52 Week High | $1.44 | |||
| Open | $5.34 | 52 Week Low | $0.06 | |||
| Day High | $5.42 | P/E | N/A | |||
| Day Low | $5.31 | EPS | $-1.24 | |||
| Volume | 2,006,649 | |||||
